Related Experiment Video
Updated: Apr 7, 2026
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Concentration-dependent differential effects of an epothilone analog on cell cycle and p53 signaling
Fan An1, Wei-Jie Zhao1, Li Tang1
1Research Center for Molecular Medicine, Dalian University of Technology, Dalian, Liaoning 116023, P.R. China.
Abstract:
The tumor-suppressor protein p53 is considered to be one of the most important transport hubs of cell signal transduction, playing critical roles in the control of cell cycle arrest, apoptosis and many other processes as a nuclear transcription factor. p53 also acts in the cytoplasm to trigger apoptosis. Paclitaxel and other microtubule inhibitors can inhibit the growth of different types of cancer cells and induce apoptosis which is believed to be p53-independent. In the present study, we demonstrated that UTD1, a genetically engineered epothilone analog and a new microtubule inhibitor, activated p53 as a transcription factor at low concentrations demonstrated by its enhanced transcriptional activity and accumulation of p21, which led to cell cycle arrest. However, at high concentrations of UTD1, p53 was accumulated in the cytoplasm which contributed to induction of apoptosis. These observations indicate that the epothilone analog has differential effects on intracellular signaling and implies that p53 plays different roles in cells exposed to different concentrations of the anticancer agent.
Insights
The novel microtubule inhibitor UTD1 differentially affects the tumor suppressor protein p53. Low UTD1 concentrations activate nuclear p53 for cell cycle arrest, while high concentrations induce cytoplasmic p53 for apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor protein p53 is crucial in cell signaling, regulating cell cycle arrest and apoptosis.
- Microtubule inhibitors like paclitaxel are used in cancer therapy, often inducing apoptosis independently of p53.
- The precise roles of p53 in response to novel anticancer agents require further elucidation.
Purpose of the Study:
- To investigate the effects of UTD1, a novel epothilone analog and microtubule inhibitor, on the tumor suppressor protein p53.
- To determine the concentration-dependent roles of p53 in UTD1-induced cellular responses.
- To explore the implications of p53's differential localization and activity in cancer treatment.
Main Methods:
- Treatment of cancer cells with varying concentrations of UTD1.
- Assessment of p53 transcriptional activity and protein accumulation.
- Analysis of p21 expression levels.
- Evaluation of cell cycle progression and apoptosis induction.
Main Results:
- Low concentrations of UTD1 enhanced p53 transcriptional activity and p21 accumulation, leading to cell cycle arrest.
- High concentrations of UTD1 caused p53 accumulation in the cytoplasm, contributing to apoptosis induction.
- These findings demonstrate a concentration-dependent, dual role for p53 in response to UTD1.
Conclusions:
- UTD1 exhibits differential effects on intracellular signaling pathways.
- p53 acts as a transcription factor in the nucleus at low UTD1 concentrations, inducing cell cycle arrest.
- p53 functions in the cytoplasm at high UTD1 concentrations, promoting apoptosis, highlighting its complex role in mediating anticancer effects.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:38Mitogens and the Cell Cycle
02:23Abnormal Proliferation
02:36DNA Damage Can Stall the Cell Cycle
02:36DNA Damage can Stall the Cell Cycle
01:23Negative Regulator Molecules